midaglizole has been researched along with Insulinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dan, K; Hirose, H; Maruyama, H; Nakamura, K; Saruta, T; Seto, Y | 1 |
| Hanafusa, T; Itoh, H; Kawachi, M; Kiyokawa, H; Kono, N; Mineo, I; Namba, M; Tarui, S; Yamada, Y; Yamasaki, T | 1 |
2 other study(ies) available for midaglizole and Insulinoma
| Article | Year |
|---|---|
Effects of alpha 2-adrenergic agonism, imidazolines, and G-protein on insulin secretion in beta cells.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Cricetinae; Glucose; GTP-Binding Proteins; Humans; Imidazoles; Indoles; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Kinetics; Molecular Structure; Oxymetazoline; Pancreatic Neoplasms; Pertussis Toxin; Phentolamine; Pyrroles; Quinolizines; Receptors, Adrenergic, alpha-2; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1997 |
Exaggerated insulin secretory response in patients with insulinomas to midaglizole, a drug with alpha 2-adrenergic blocking activity.
Topics: Adenoma, Islet Cell; Aged; Blood Glucose; Female; Humans; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Male; Middle Aged; Pancreatic Neoplasms | 1988 |